Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Agentic AI Driving the Next Phase of Continuous Evidence Generation in Pharma

2026 Prediction #4: Agentic AI Driving the Next Phase of Continuous Evidence Generation in Pharma

For years, the pharmaceutical industry has followed a familiar evidence cycle. Teams design a clinical trial, execute it, lock the database, analyze the results, and wait for another study to address remaining questions. They wait for post-market surveillance to reveal real-world outcomes and for regulators or payers to request additional data before reimbursement decisions. However,…

Read More

MadeAi | 2026 Prediction #3: Role-Based Tool Isolation: The Gold Standard for Secure Pharma AI

2026 Prediction #3: Role-Based Tool Isolation: The Gold Standard for Secure Pharma AI

The pharmaceutical industry is currently at a pivotal moment in the AI landscape. After years of cautious AI experimentation limited to isolated labs and pilot programs, something fundamentally different is unfolding in 2026. The central question has shifted from “Does AI work?” to “How do we deploy it safely and at scale?” especially in organizations…

Read More

Literature Reviews

Complete Guide to GenAI-enabled Literature Review for Life Sciences: MadeAi vs. Competitors

Every professional in the life sciences knows the feeling: literature review is challenging, time-consuming, and above all, exhausting. This essential step in research can feel like a massive hurdle, slowing down innovation and consuming countless hours. Recognizing this frustration, MadeAi developed MadeAi-LR, a powerful GenAI-enabled solution designed to transform the literature review process. It provides…

Read More

Real Reviews

AI in Action: Real Results from Real Reviews

As the demands for faster, more accurate, and scalable literature reviews rise in life sciences, AI is no longer just a future promise—it’s a proven performance driver. Systematic literature review (SLR) teams, especially in HEOR and medical affairs, are adopting GenAI platforms not just for experimentation but to solve long-standing bottlenecks in screening, extraction, and…

Read More